2022
DOI: 10.1007/s12350-021-02661-3
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological stress myocardial perfusion imaging after an inadequate exercise stress test

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 14 publications
0
1
0
Order By: Relevance
“…In rodents, regadenoson was found to transiently disrupt the BBB, allowing entry of a 70 kD dextran, disabling p-glycoprotein pumps, and facilitating the entry of lymphocytes into the brain. Regadenoson is FDA approved for patients who need a cardiac stress test but cannot walk on a treadmill [ 59 ]. There have been three pilot studies evaluating whether regadenoson administered at the FDA-approved dose for cardiac stress tests is able to open the BBB in patients.…”
Section: Resultsmentioning
confidence: 99%
“…In rodents, regadenoson was found to transiently disrupt the BBB, allowing entry of a 70 kD dextran, disabling p-glycoprotein pumps, and facilitating the entry of lymphocytes into the brain. Regadenoson is FDA approved for patients who need a cardiac stress test but cannot walk on a treadmill [ 59 ]. There have been three pilot studies evaluating whether regadenoson administered at the FDA-approved dose for cardiac stress tests is able to open the BBB in patients.…”
Section: Resultsmentioning
confidence: 99%